Time Medical International Ventures (India) Pvt Ltd, a wholly owned subsidiary of Fischer Medical Ventures Limited, announces partnership for Installation of Inter-Op MRI Suite.

FISCHER MEDICAL VENTURES LIMITED Registered Office Address: Survey No. 480/2 AP Medtech Zone Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032 CIN: L86900AP1993PLC118162 Email: enquiry@fischermv.com | Website: www.fischermv.com | Contact 9080966548 July 31st, 2026 To To BSE Limited National Stock Exchange of India Ltd. Corporate Relationship Department Exchange Plaza, 5tll floor 25th Floor, P J Towers Plot No. C/ 1, G Block, Dalal Street, Fort, Bandra-Kurla Complex Bandra (E), Mumbai – 400 001 Mumbai - 400 051 BSE Scrip Code: 524743 NSE Symbol: FISCHER Dear Sir/Madam, Reg : Press Release on Time Medical International Ventures (India) Pvt Ltd, a wholly owned subsidiary of Fischer Medical Ventures Limited, announces partnership for installation of Inter-Op MRI Suite We enclose a press release regarding Time Medical International Ventures (India) Pvt Ltd, a wholly owned subsidiary of Fischer Medical Ventures Limited, announces partnership for installation of Inter-Op MRI Suite, for dissemination. Thanking you, Yours Truly, For FISCHER MEDICAL VENTURES LIMITED BALAJI GANDLA COMPANY SECRETARY & COMPLIANCE OFFICER Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006 CIN L86900AP1993PLC118162 Corporate Office : Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006 Registered : No. 480/2 AP Medtech Zone, Nadupura Village, Office Pedagantyadu Mandal, Visakhapatnam, 530032 Time Medical International Ventures (India) Pvt Ltd, a wholly owned subsidiary of Fischer Medical Ventures Limited, announces partnership for installation of Inter-Op MRI Suite. Chennai, India – 31st July 2026 – Time Medical International Ventures (India) Private Limited (“Time Medical India”), a wholly owned subsidiary of Fischer Medical Ventures Limited and a global leader in advanced medical imaging solutions, has entered into a partnership with Parul Sevashram Hospital, Vadodara, to install its revolutionary DRIS–iMRI Medharanya Suite, an AI-enabled next-generation portable intraoperative MRI system. Time Medical has developed a revolutionary new variant of MRI imaging technology — DRIS– iMRI Medharanya, an AI-enabled, next-generation, portable and specialized MRI system integrating Augmented Reality (AR), Artificial Intelligence (AI), Machine Learning (ML), and Exoscope technologies. The intraoperative MRI platform is designed to transform intraoperative imaging by providing surgeons with real-time visualization during complex neurosurgical procedures, enabling unprecedented precision, safety, and surgical control in procedures that traditionally rely on limited visual feedback. Time Medical International Ventures has entered into a partnership to install its first Modern Brain Suite: the DRIS–iMRI Medharanya system at Parul Sevashram Hospital, Vadodara. Parul Sevashram Hospital’s vision of “Health for All” and its commitment to accessible, high-quality healthcare closely aligns with TMIV’s focus on expanding access to advanced imaging technologies and improving clinical outcomes through innovation-driven diagnostics and interventional solutions. Parul Sevashram Hospital serves as the teaching hospital of Parul Institute of Medical Sciences & Research, a constituent institute of Parul University, Vadodara — one of India's largest multidisciplinary private universities and the youngest in the country to receive a NAAC A++ accreditation in its first assessment cycle. Spread across a 125-acre eco-friendly campus, Parul University comprises 34 constituent institutes offering 250+ programmes across 21 faculties, including Medicine, Engineering, Pharmacy, Ayurveda, Homoeopathy, Management, Law, and Design, to a student community of over 43,000, including more than 2,500 international students from over 68 countries. Through this upcoming partnership, the DRIS–iMRI Medharanya Suite is expected to strengthen the university's academic and clinical ecosystem, giving medical students, residents, and faculty at Parul University hands-on exposure to next-generation neurosurgical imaging technology. Source: Parul University institutional profile, as published on the university's official website (paruluniversity.ac.in) and its member listing with EURASHE (European Association of Institutions in Higher Education). Medharanya Brain Suite OT is the next-generation integrated ecosystem encompassing not only the intraoperative imaging through MRI -DRIS but also neurophysiology navigation , exoscope solution , machine vision, VR-AR and robotronics in one intelligent surgical ecosystem. The DRIS–iMRI Medharanya platform integrates advanced imaging modalities to seamlessly unify diagnostic and surgical workflows into a single, real-time clinical ecosystem, enabling faster decision-making, unparalleled visualization of complex neurological anatomy beyond conventional imaging, reduced surgical time with enhanced patient safety through intraoperative guidance and verification, and integrated pre-operative planning with intra-operative confirmation to support precision-driven neurosurgical execution. DRIS–iMRI Medharanya is being jointly developed by TMIV in collaboration with Dr. Iype Cherian, a globally renowned neurosurgeon, educator, and innovator. TMIV worked closely with surgeons to understand their real-world requirements in building the solution. Dr. Cherian completed his M.Ch (Neurosurgery) at CMC Vellore and advanced fellowship training in Skull Base and Vascular Neurosurgery at Nagoya, Japan. He is internationally recognized for pioneering neurosurgical techniques, including novel craniotomy approaches and the concept of Brain Cooling, influencing modern neurosurgical practice and postoperative recovery strategies. “Our upcoming partnership with Parul Sevashram Hospital to install the DRIS–iMRI Medharanya will mark a landmark deployment of a next-generation intraoperative MRI Brain Suite in India. This collaboration is expected to enhance neurosurgical precision, improve clinical outcomes, and strengthen advanced neurocare capabilities at the hospital.”- Ms. Svetlana Rao, Director, Time Medical India About Time Medical International Ventures (India) Private Limited Time Medical International Ventures (India) Private Limited is a global leader in advanced medical imaging solutions and a wholly owned subsidiary of Fischer Medical Ventures Limited. Headquartered in Chennai, Time Medical India specializes in the design and manufacture of high-performance, cost-effective MRI systems that democratize access to advanced diagnostic imaging across emerging and developed markets alike. For further information, please contact: Fischer Medical Ventures Limited Email: enquiry@fischermv.com Website: www.fischermv.com Contact: 9080966548 Disclaimer: This investor release is not an offer to sell any securities or a solicitation to buy any securities of Fischer Medical Ventures Limited (the "company") or its subsidiaries (together with the company, the "group"). Certain statements in this document may be forward looking statements. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", " estimates"," anticipates", " projects", " expects", " intends", " may", " will"," or " or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, aims, objectives, goals, future events or intention. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local political or economic developments, technological risks, and many other factors that could cause our actual results to differ materially from those contemplated by the relevant forward-looking statements. Forward looking statements are not guarantees of future performance including those relating to general business plans and strategy of the Company, its future outlook and growth prospects, and future [Showing first 8,000 characters — download PDF for full document]